Breaking News Instant updates and real-time market news.

MYGN

Myriad Genetics

$18.63

0.01 (0.05%)

14:00
10/17/16
10/17
14:00
10/17/16
14:00

Myriad jumps after saying it will present four new studies at ASHG

Earlier today, Myriad Genetics announced it will present four new studies at the American Society of Human Genetics Annual Meeting being held Oct. 18-22 in Vancouver, British Columbia. The research being presented highlights the clinical utility of Myriad's myVision Variant Classification Program and myRisk Hereditary Cancer gene panel test. "Precision medicine is dependent on the accuracy of the information being provided to patients, and Myriad's myVision is the most advanced variant classification program available to determine whether a patient's genetic mutation is benign or deleterious," said Johnathan Lancaster, M.D., Ph.D, chief medical officer, Myriad Genetic Laboratories. "At ASHG, we are excited to present four new studies, which advance the state of the art of genetic testing and meet the scientific needs of researchers and clinicians." shares of Myriad Genetics are up 87c or 4.65% to $19.50 per share.

MYGN Myriad Genetics
$18.63

0.01 (0.05%)

08/29/16
BOFA
08/29/16
NO CHANGE
BOFA
Myriad Genetics loses BCBS of Nevada contract to LabCorp, says BofA/Merrill
Analysts at BofA Merrill Lynch noted that Myriad Genetics (MYGN) has lost an in-network contract with Blue Cross Blue Shield of Nevada to LabCorp (LH) and the firm expects Myriad shares to trade down following the news. The firm sees the potential for a continuation of this trend across other BCBS systems in other states.
10/10/16
LTCO
10/10/16
DOWNGRADE
Target $16
LTCO
Sell
Myriad Genetics downgraded to Sell from Neutral at Ladenburg
Ladenburg Thalmann analyst Kevin DeGeeter downgraded Myriad Genetics (MYGN) to Sell citing a "significant and unexpected deterioration" in outlook for the company's companion diagnostic franchise. The analyst expects a lower growth outlook to drive "significant P/E multiple compression." Tesaro (TSRO) presented data this weekend that suggested its PARP inhibitor niraparib was active in a maintenance setting for recurrent ovarian cancer in patients with either positive or negative HRD scores. The analyst had expected the drug to benefit only HRD positive patients. As such, the use of niraparib will not require HRD testing, DeGeeter tells investors in a research note. The analyst has a $16 price target for the shares.
10/10/16
PIPR
10/10/16
NO CHANGE
PIPR
Neutral
TESARO data suggest Myriad test not necessary, says Piper Jaffray
Piper Jaffray analyst William Quirk points out that data over the weekend from TESARO (TSRO), Myriad Genetics' (MYGN) companion diagnostic partner, suggest niraparib works in all-comers, making Myriad's test not necessary. Myriad shares may be down physiologically, Quirk tells investors in a research note partially titled "When A Partnership Produces Mixed Results." The analyst, however, believes niraparib is not clinically significant in HRD negative patients and that Myriad's test will be included on the drug label. He keeps a Neutral rating on shares of Myriad. Ladenburg Thalmann this morning downgraded the stock to Neutral.
10/10/16
10/10/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Honeywell (HON) downgraded to Buy from Conviction Buy at Goldman with analyst Christopher Glynn lowering his Q3 Earnings Per Share expectations for Honeywell after the company cut its earnings and revenue outlook and trimmed his price target to $122 from $128. 2. United Technologies (UTX) downgraded to Neutral from Buy at Citi with analyst Jason Gursky saying he sees three issues limiting share upside over the next twelve-plus months. 3. PNC Financial (PNC) was downgraded to Neutral from Buy at Nomura while the firm downgraded Fifth Third (FITB) to Reduce from Neutral. 4. Myriad Genetics (MYGN) downgraded to Sell from Neutral at Ladenburg with analyst Kevin DeGeeter citing a "significant and unexpected deterioration" in outlook for the company's companion diagnostic franchise. 5. HSN, Inc. (HSNI) downgraded to Hold from Buy at Craig-Hallum with analyst Alex Fuhrman saying his channel checks indicate continued weakness in the third quarter, with particular weakness in jewelry and consumer electronics. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

08:35
04/25/17
04/25
08:35
04/25/17
08:35
General news
Bullish momentum on U.S. equities »

Bullish momentum on U.S.…

IBM

IBM

$160.75

0.37 (0.23%)

, GSK

GlaxoSmithKline

$41.12

0.34 (0.83%)

08:34
04/25/17
04/25
08:34
04/25/17
08:34
Hot Stocks
The Weather Company renews collaboration with GSK Consumer Healthcare »

The Weather Company, an…

IBM

IBM

$160.75

0.37 (0.23%)

GSK

GlaxoSmithKline

$41.12

0.34 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 07

    May

  • 06

    Jun

ECOM

ChannelAdvisor

$11.65

-0.1 (-0.85%)

, EBAY

eBay

$32.05

-0.13 (-0.40%)

08:34
04/25/17
04/25
08:34
04/25/17
08:34
Hot Stocks
ChannelAdvisor announces strategic partnership with eBay »

ChannelAdvisor…

ECOM

ChannelAdvisor

$11.65

-0.1 (-0.85%)

EBAY

eBay

$32.05

-0.13 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 18

    May

MRVL

Marvell

$15.06

0.16 (1.07%)

, AVGO

Broadcom

$221.24

3.58 (1.64%)

08:34
04/25/17
04/25
08:34
04/25/17
08:34
Hot Stocks
Marvell appoints Neil Kim as CTO »

Marvell (MRVL) announced…

MRVL

Marvell

$15.06

0.16 (1.07%)

AVGO

Broadcom

$221.24

3.58 (1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$45.90

1.81 (4.11%)

08:34
04/25/17
04/25
08:34
04/25/17
08:34
Hot Stocks
Sanofi: Aubagio had significant effect on reducing cortical gray matter atrophy »

Sanofi Genzyme, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 03

    May

IMMR

Immersion

$8.66

0.18 (2.12%)

08:33
04/25/17
04/25
08:33
04/25/17
08:33
Hot Stocks
Immersion signs multiyear license renewal with ALPS »

Immersion Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$907.41

8.88 (0.99%)

08:33
04/25/17
04/25
08:33
04/25/17
08:33
Periodicals
Amazon opens Amazon Global Selling office in Taiwan, DigiTimes says »

Amazon has opened an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 16

    May

  • 23

    May

PZRX

PhaseRx

$1.91

0.67 (54.03%)

08:33
04/25/17
04/25
08:33
04/25/17
08:33
Hot Stocks
PhaseRx receives 'positive' opinion for orphan drug designation for PRX-OTC »

PhaseRx announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDTX

Cidara Therapeutics

$7.20

0.15 (2.13%)

08:32
04/25/17
04/25
08:32
04/25/17
08:32
Hot Stocks
Cidara Therapeutics promotes Taylor sandison to chief medical officer »

Cidara Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DMPI

DelMar Pharmaceuticals

$2.70

-0.1 (-3.57%)

08:32
04/25/17
04/25
08:32
04/25/17
08:32
Hot Stocks
DelMar Pharma enters into collaboration with Duke University for VAL-083 »

DelMar Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSIS

OSI Systems

$72.27

0.63 (0.88%)

08:31
04/25/17
04/25
08:31
04/25/17
08:31
Hot Stocks
OSI Systems awarded $7M contract to provide checkpoint inspection systems »

OSI Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 06

    Jun

BNED

Barnes & Noble Education

$10.38

0.08 (0.78%)

08:31
04/25/17
04/25
08:31
04/25/17
08:31
Hot Stocks
Barnes & Noble Education names Michael Miller chief legal officer »

Barnes & Noble…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

08:31
04/25/17
04/25
08:31
04/25/17
08:31
Options
One option delisting on April 25th »

Option delistings…

LLY

Eli Lilly

$83.42

1.53 (1.87%)

08:30
04/25/17
04/25
08:30
04/25/17
08:30
Technical Analysis
Eli Lilly trades lower after earnings and outlook »

The shares were last…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 04

    May

  • 07

    May

  • 31

    May

BIDU

Baidu

$180.03

1.95 (1.10%)

, NFLX

Netflix

$143.83

0.96 (0.67%)

08:28
04/25/17
04/25
08:28
04/25/17
08:28
Technical Analysis
Netflix edges up to 52-week highs in pre-market trading »

Shares were last at…

BIDU

Baidu

$180.03

1.95 (1.10%)

NFLX

Netflix

$143.83

0.96 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 05

    Jun

ANTM

Anthem

$168.41

0.61 (0.36%)

, ESRX

Express Scripts

$67.25

0.79 (1.19%)

08:28
04/25/17
04/25
08:28
04/25/17
08:28
Recommendations
Anthem, Express Scripts analyst commentary  »

Anthem contract…

ANTM

Anthem

$168.41

0.61 (0.36%)

ESRX

Express Scripts

$67.25

0.79 (1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 18

    May

  • 06

    Jun

WAT

Waters

$160.27

1.75 (1.10%)

08:26
04/25/17
04/25
08:26
04/25/17
08:26
Earnings
Waters sees FY17 EPS $7.20-$7.40, consensus $7.04 »

Sees a mid single digit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

AAPL

Apple

$143.64

1.37 (0.96%)

, CBS

CBS

$65.95

-0.89 (-1.33%)

08:25
04/25/17
04/25
08:25
04/25/17
08:25
Periodicals
Apple Music delays release of first series 'Carpool Karaoke,' Reuters reports »

Apple's Apple Music…

AAPL

Apple

$143.64

1.37 (0.96%)

CBS

CBS

$65.95

-0.89 (-1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 04

    May

  • 15

    Jun

WAT

Waters

$160.27

1.75 (1.10%)

08:25
04/25/17
04/25
08:25
04/25/17
08:25
Earnings
Waters sees Q2 EPS $1.65-$1.75, consensus $1.67 »

Sees strong mid-single…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

08:25
04/25/17
04/25
08:25
04/25/17
08:25
Conference/Events
The Washington Journal holds a discussion on Dodd-Frank »

Manhattan Institute…

WHR

Whirlpool

$174.80

3.29 (1.92%)

08:22
04/25/17
04/25
08:22
04/25/17
08:22
Hot Stocks
Whirlpool sees 3%-5% annual organic net sales growth, 10%+ EBIT margin by 2020 »

Says fundamentals of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 04

    May

$DJT

DJ Transportation Average

08:21
04/25/17
04/25
08:21
04/25/17
08:21
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

08:20
04/25/17
04/25
08:20
04/25/17
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

08:20
04/25/17
04/25
08:20
04/25/17
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$167.06

2.65 (1.61%)

08:20
04/25/17
04/25
08:20
04/25/17
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.